Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma

Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma / Voskuilen, C.s., Oo, H.z., Genitsch, V., Smit, L.a., Vidal, A., Meneses, M., Necchi, A., Colecchia, M., Xylinas, E., Fontugne, J., Sibony, M., Roupret, M., Lenfant, L., Cote, J.f., Buser, L., Saba, K., Furrer, M.a., van der Heijden, M.s., Daugaard, M., Black, P.c., et al.. - In: THE AMERICAN JOURNAL OF SURGICAL PATHOLOGY. - ISSN 0147-5185. - 43:12(2019), pp. 1600-1610. [10.1097/PAS.0000000000001371]